ClinicalTrials.govpublic full text
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
dermatitis, atopic, atopic dermatitis, prograf, tacrolimus, fk506, tacrolimus ointment, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870504
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.